STATE-OF-THE-ART OF SEROGROUP B STREPTOCOCCUS-INDUCED INFECTIONS AT THE PRESENT STAGE


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The paper reviews the literature on the infections caused by Serogroup B streptococci (S. agalactiae). It considers the biological and environmental features of this microorganism and its pathogenic properties. A population group that is most susceptible to this microorganism and procedures for the prevention and treatment of infections caused by Streptococci of this group are described.

Texto integral

Acesso é fechado

Sobre autores

O. CHUCHUKINA

Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: olgnest1009@yandex.ru
Moscow

Igor BOCHKOV

Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: bochkovia@mail.ru
Moscow

Bibliografia

  1. Рождественская А.С. Двухкомпонентная регуляторная система SAK188/SAK189 и ее влияние на свойства Streptococcus agalactiae. Автореф. дис.. канд. мед. наук. СПб, 2011.
  2. Gardam M.A., Low D.E., Saginur R. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch. Intern. Med. 1998; 158: 1704-1708.
  3. Тотолян А.А., Грабовская К.В. Стрептококки группы В в неонатальной патологии: механизм патогенного действия, диагностика и профилактика. Вестник АМН СССР 1990; 7: 36-40.
  4. Christensen K.K., Christensen P. Chlorhexidine for prevention of neonatal colonization with GBS. In: Christensen K.K., Christensen P., Ferrieri P. Neonatal group B streptococcal infection. Antibiotiсs and Chemotherapy. Basel: Karger, 1985; 348.
  5. Костюкова Н.Н., Абрикосова Н.Ю., Медведева С.Н. Стрептококк группы В при менингите и сепсисе новорожденных. ЖМЭИ1984; 9: 25-28.
  6. Зациорская С.А., Башмакова М.В. Калашникова Е.Н. Генерализованная инфекция плода и новорожденного, вызванная стрептококками группы В. Вопр. охраны материнства и детства 1987; 11: 60-62.
  7. Башмакова М.А., Кошелева Н.Г. Калашникова Е.П. Инфекция и бактериальная колонизация урогениталий у беременных, влияние на течение беременности, плода и новорожденного. Акуш. и гин. 1995; 1; 15-18.
  8. Бочков И.А., Семина Н.А., Шувчук М.С. Эпидемиологические и экологические особенности инфекций, вызываемых стрептококками сергруппы В у беременных женщин и новорожденных детей. Эпидемиол. и инфекц. бол. 2000; 2: 56-59.
  9. Apgar B. S., Greenberg G., Yen G. Prevention of group B streptococcal disease in the newborn. B. Am. Fam. Physician. 2005; 71 (5): 903-910.
  10. Luck S., Torny M., d’Agapeyeff K., Pitt A., Heath P., Breathnach A., Russell A.B. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003; 361: 1953-1954.
  11. Nandyal R.R. Update on group B streptococcal infections: perinatal and neonatal periods. J. Perinat. Neonatal. Nurs. 2008; 22 (3): 230-237.
  12. Schuchat A., Zywicki S.S., Dinsmoor M. J. et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000; 105: 21-26.
  13. Law M.R., Palomaki G., Alfirevic Z. et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Societ. J. Med. Screen. 2005; 12: 60-68.
  14. Berner R. Infektionen durch Gruppe B streptokokken in der neonatalperiode. Monatsschr. Kinderheild. 2003; 151: 373-383.
  15. Lauer P., Rinaudo C.D., Soriani M. et al. Genome analysis reveals pili in group B streptococci. Science 2005; 309: 105.
  16. Rinaudo C.D., Rosini R., Galeotti C.L. et al. Specific invovement of Pulis Type 2a in biofilm formation in Group B streptococcus. PLoS ONE 2010; 5, Issue 2: e9216.
  17. Kimura K., Suzuki S., Wachino J. et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 2008; 52(6): 1326-1328.
  18. Брико М.И., Покровский В.И. Инфекции, вызываемые Streptococcus agalactiae. В кн.: В.И. Покровский, Н.И. Брико, Л.А. Ряпис. Стрептококки и стрептококкозы. М.: ГЭОТАР-Медиа, 2006. 546 с.
  19. Врожденные, перинатальные и неонатальные инфекции. Под ред. А. Гриноу, Дж. Осборна, Ш.Сазерленд. Пер. с англ. М.: Медицина, 2000; 288.
  20. Стрептококковая инфекция у детей. Учебно-методическое пособие. Под ред. проф. В.А. Воробьевой. Н. Новгород: Издательство НГМА, 2005. 80 с.
  21. Анкирская А.С. Роль стрептококков группы В в перинатальной патологии. Акуш. и гин. 1984; 9: 6-10.
  22. Red Book: Report of the Committee on Infectious Diseases. 27h ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006; 992.
  23. Baker C.J. Group B streptococcal infections. In: Baker C.J., Edwards M.S., Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders, 2001; 1091-1156.
  24. Baltimore R.S. Huie S.M., Meek J.I., Schuchat A. Early-onset neonatal sepsis in the era of group В streptococcal prevention. Pediatrics 2001; 108: 1094-1098.
  25. Boyer K.M. Neonatal group В streptococcal infections. Current Opinion Pediatrics 1995; 7: 13-18.
  26. Kenyon S.L., Taylor PJ., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes, ORACLE Collaborative Group. Lancet 2001; 357: 979-988.
  27. Николаева И.В. Стрептококковая инфекция группы В у новорожденных и грудных детей. Лечащий врач 2012; 1: 26.
  28. Van Dyke M.K., Phares C.R., Lynfield R. et al. Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 2009; 360: 2626-2636.
  29. Anthony B.F., Eisenstadt R., Carter J. et al. Genital and intestinal carriage of group B streptococci during pregnancy. J. Infect. Dis. 1981; 143: 761-766.
  30. Anthony B.F., Carter J., Eisentadt R., Rimer D.G. Carriage of group B streptococci during pregnancy: A puzzler. J. Infect. Dis. 1983; 147: 776.
  31. Маянский А.Н. Стрептококки: микробиология и патология. Вопросы диагностики в педиатрии 2010; 1: 9-19.
  32. Christian J. W., Charles S. L. Streptocоccus group B infections. eMedicine, Nov. 11, 2009. http://emedicine. medscape.com
  33. Eschenbach D.A. Specific bacterial infections: Group B streptococcus. GLOWM, 2009; 1756-2228.
  34. Simoes J.A., Alves V.M., Fracalanzza S.E. et al. Phenotypical characteristics of group B streptococcus in parturients. Braz. J. Infect. Dis. 2007; 11(2): 120-129.
  35. Barcaite E., Bartusevicius A., Tameliene R. et al. Prevalence of maternal group B streptococcal colonization in European countries. Acta Obstet. Gynecol. Scand. 2008; 87(3): 260-271.
  36. Kieran E., Matheson M., Mann A.G. et al. Group B streptococcus (GBS) colonization among expectant Irish mothers. Ir. Med. J. 1998; 91(1): 21-22.
  37. Lee B.K., Song Y.R., Kim M.Y. et al. Epidemiology of group B streptococcus in Korea pregnant women. J. Epidemiol. Infect. 2010; 138(2): 292-298.
  38. Ming-Jie Jang, Pi-Lin San, Kuo-Chang Wen et al. Prevalence of maternal group B streptococcus colonization and vertical transmission in low-risk women in a single institute. Journal of the Chinese Medical Association. 2012; 75: 25-28.
  39. Kubin V., Mrasticova H., Pavlova M. et al. Group B streptococcal infections. Zbl. Bact. Abt. Orig. 1987; A265(1-2): 210-217.
  40. Jackson L.A., Hilsdon R., Farlley M.M. et al. Risk factors for group B streptococcal disease in adults. Ann. Int. Med. 2004; 123(6): 415-420.
  41. Кудин А.П., Маржало Е.Ю. Клинические особенности и этиотропное лечение менингита, вызванного Streptococcus agalactiae, у детей. Мед. журн. 2012; 3: 135-138.
  42. Larsen B. Microbiology of the female genital tract. In: Pastorek J.G. (ed.): Obstetric and Gynecologic Infectious Disease. New York: Raven Press, 1994; 11-25.
  43. Ayaub E.M., Swingle H. Pathogenic mechanisms in neonatal GBS infection. In: Christensen K.K., Christensen P., Ferrieri P. Neonatal group B streptococcal infection. Antibiotics and Chemotherapy. Basel: Karger, 1985; 128-141.
  44. Hakansson S., Axemo P., Bremme K. et al. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonization. Acta Obstet. Gynecol. Scand. 2008; 87(3): 258-259.
  45. Prevention of perinatal group B streptococcal desiase-revised guidelines from CDC. MMWR Recom. Rep. 2010; 59(RR-10): 14.
  46. Centers for Disease Control and Prevent. MMWR 1996; 45: 1-24.
  47. Centers for Disease Control and prevention (CDC). Prevention of perinatal group В streptococcal disease: Revised Guidelines from CDC. MMWR 2002; 51: 10-22.
  48. Anon. Trends in prenatal group B streptococcal disease -United States, 2000-2006. MMWR 2009; 58(5): 109-112.
  49. Estrany X.C. Probable early onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Arch. Dis. Child. Fetal Neonatal. 2008; 93: 85-89.
  50. Johri А.К. Group B streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 2006; 4: 932-942.
  51. Heath P.T., Feldman R. G. Vaccination against group B streptococcus. Expert. Rev. Vaccines 2005; 4: 207-218.
  52. Jordan H.T., Farley M.M., Graig A. Revisiting the need for vaccine prevention of late onset neonatal group B streptococcal disease: a multistate, population based analysis. Pediatric. Infect. Dis. 2008; 27: 1057-1064.
  53. Wiswell T.E., Baumgart S., Gannon C.M., Spitzer A.R. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed. Pediatrics 1995; 95: 803-806.
  54. Turrentine M.A., Ramirez M.M. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstet. Gynecol. 2008; 112(2, part 1): 259-264.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies